AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 144 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $17,000 | -85.6% | 24,241 | -53.5% | 0.00% | – |
| Q4 2021 | $118,000 | +63.9% | 52,146 | +108.3% | 0.00% | -100.0% |
| Q3 2021 | $72,000 | -26.5% | 25,033 | -2.8% | 0.00% | 0.0% |
| Q2 2021 | $98,000 | +28.9% | 25,765 | +15.1% | 0.00% | -66.7% |
| Q1 2021 | $76,000 | +20.6% | 22,384 | 0.0% | 0.00% | +50.0% |
| Q4 2020 | $63,000 | +12.5% | 22,384 | +0.5% | 0.00% | 0.0% |
| Q3 2020 | $56,000 | -80.2% | 22,266 | +6.9% | 0.00% | -84.6% |
| Q2 2020 | $283,000 | +102.1% | 20,820 | +13.0% | 0.01% | +333.3% |
| Q1 2020 | $140,000 | +15.7% | 18,426 | -4.1% | 0.00% | +50.0% |
| Q4 2019 | $121,000 | +75.4% | 19,206 | +9.7% | 0.00% | +100.0% |
| Q3 2019 | $69,000 | -19.8% | 17,503 | -1.2% | 0.00% | -50.0% |
| Q2 2019 | $86,000 | -21.8% | 17,713 | +32.4% | 0.00% | -33.3% |
| Q1 2019 | $110,000 | +52.8% | 13,377 | +3.4% | 0.00% | +50.0% |
| Q4 2018 | $72,000 | – | 12,939 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
| GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
| Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
| DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
| Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
| Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
| Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
| Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
| Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
| Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |